Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Ozempic and Mounjaro are covered when prescribed for type 2 diabetes, also on Tier 3 with PA
GLP-1R/GIPR-Targeting Drugs GLP-1 Peptide Drugs Novo Nordisk's semaglutide-based medicinesWegovy, Ozempic, and Rybelsushave significantly advanced the management of obesity and type 2 diabetes
Given that GLP-1R agonists have superior weight loss effects and good safety, some of its products have been officially approved by FDA for chronic weight management of obese or overweight adults
Insurance coverage varies, but many plans now cover these medications for weight loss, especially if you have related health conditions
US$ 23.82
US$ 23.91
US$ 28.65
US$ 22.94
US$ 28.77
US$ 29.03
US$ 28.96
